Queen's University at Kingston
π¨π¦Canada
- Country
- π¨π¦Canada
- Ownership
- Private
- Established
- 1841-10-16
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.queensu.ca
Early Genomic Testing for Inherited Bleeding Disorders
Not Applicable
Not yet recruiting
- Conditions
- First Posted Date
- 2024-12-16
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Queen's University
- Target Recruit Count
- 212
- Registration Number
- NCT06736158
- Locations
- π¨π¦
Queen's University/Kingston Health Sciences Centre, Kingston, Ontario, Canada
π¨π¦The Ottawa Hospital, Ottawa, Ontario, Canada
π¨π¦Unity Health, Toronto, Ontario, Canada
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Phase 3
Not yet recruiting
- Conditions
- First Posted Date
- 2024-11-13
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Canadian Cancer Trials Group
- Target Recruit Count
- 320
- Registration Number
- NCT06686771
Pilot Feasibility Study of a Pragmatic Mixed-Methods Randomized Controlled Trial on a Follow-Up Bundle of Care for ICU Survivors and Caregivers
Not Applicable
Recruiting
- Conditions
- First Posted Date
- 2024-11-08
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Queen's University
- Target Recruit Count
- 40
- Registration Number
- NCT06681649
- Locations
- π¨π¦
Queen's University, Kingston, Ontario, Canada
Palliative Steroeotactic Body Radiotherapy vs Palliative Standard Radiotherapy in Patients With Advanced Head and Neck Cancer
Phase 3
Not yet recruiting
- Conditions
- First Posted Date
- 2024-10-15
- Last Posted Date
- 2024-10-15
- Lead Sponsor
- Canadian Cancer Trials Group
- Target Recruit Count
- 196
- Registration Number
- NCT06641791
Canadian Initiative to Measure, Predict and Assess Cancer Treatment Outcomes in Patients Treated With Immuno-Oncotherapeutics
Not yet recruiting
- Conditions
- First Posted Date
- 2024-10-08
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- Canadian Cancer Trials Group
- Target Recruit Count
- 120
- Registration Number
- NCT06630273
LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-02
- Last Posted Date
- 2024-10-02
- Lead Sponsor
- Canadian Cancer Trials Group
- Target Recruit Count
- 128
- Registration Number
- NCT06623461
Docetaxel and Hormone Treatment Compared to Hormone Treatment Alone in People With Metastatic Castration Sensitive Prostate Cancer and Less Than Optimal PSA Response
Phase 3
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-10-21
- Lead Sponsor
- Canadian Cancer Trials Group
- Target Recruit Count
- 830
- Registration Number
- NCT06592924
A Chinese Version of the Thinking Health Program for East Asian Pregnant Immigrant People in Canada
Not Applicable
Recruiting
- Conditions
- First Posted Date
- 2024-06-06
- Last Posted Date
- 2024-10-23
- Lead Sponsor
- Queen's University
- Target Recruit Count
- 50
- Registration Number
- NCT06446089
- Locations
- π¨π¦
Queen's University, Kingston, Ontario, Canada
Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes
Phase 3
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-06-03
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Canadian Cancer Trials Group
- Target Recruit Count
- 236
- Registration Number
- NCT06439225
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Supporting the National Expansion of HPV-based Cervical Cancer Screening in Tanzania Among Women Living With HIV
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-05-07
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- Queen's University
- Target Recruit Count
- 2000
- Registration Number
- NCT06402383
Β© Copyright 2024. All Rights Reserved by MedPath